TE
Tectonic Therapeutic, Inc. (TECX)
NASDAQ·Healthcare·Biotechnology
$26.80
-6.78%
Mkt Cap $535.88M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$1.11 | -$1.03 | +7.21% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$1.05 | -$1.02 | +2.86% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.98 | -$1.07 | -9.18% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$1.10 | -$0.93 | +15.45% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$1.39 | -$0.84 | +39.57% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.84 | -$1.20 | -42.86% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$1.96 | -$3.81 | -94.39% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$4.32 | -$1.80 | +58.33% | — | — |
| Q1 2024 Mar 14, 2024 | — | — | — | -$4.04 | -$2.40 | +40.59% | — | — |
| Q3 2023 Sep 29, 2023 | — | — | — | -$4.22 | -$5.81 | -37.67% | — | — |
| Q2 2023 Jun 29, 2023 | — | — | — | -$6.49 | $18.29 | +381.78% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$6.45 | -$6.80 | -5.51% | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | -$5.91 | -$6.86 | -16.00% | — | — |
| Q3 2022 Sep 29, 2022 | — | — | — | -$6.60 | -$6.30 | +4.59% | — | — |
| Q2 2022 Jun 29, 2022 | — | — | — | — | -$7.70 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$6.87 | -$8.19 | -19.32% | — | — |
| Q4 2021 Dec 30, 2021 | — | — | — | — | -$7.76 | — | — | — |
| Q3 2021 Sep 29, 2021 | — | — | — | — | -$8.97 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.74 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$7.76 | — | — | — |